IRINOTECAN PLUS OXALIPLATIN+ -G-CSF AS 2ND LINE THERAPY IN PATIENTS WITH ADVANCED 5-FU/LEUCOVORIN-REFRACTORY COLORECTAL-CANCER (CC)/

Authors
VALENCAK J LATHAN B KORNEK G RADERER M KLEIN G HEJNA M BRODOVIC T WEINLANDER G DEPISCH D SCHEITHAUER W
Citation
J. Valencak et al., IRINOTECAN PLUS OXALIPLATIN+ -G-CSF AS 2ND LINE THERAPY IN PATIENTS WITH ADVANCED 5-FU/LEUCOVORIN-REFRACTORY COLORECTAL-CANCER (CC)/, British Journal of Cancer, 78, 1998, pp. 47-47
Citations number
NO
Categorie Soggetti
Oncology
Journal title
British Journal of Cancer → ACNP
ISSN journal
00070920
Volume
78
Year of publication
1998
Supplement
1
Pages
47 - 47
Database
ISI
SICI code
0007-0920(1998)78:<47:IPO-A2>2.0.ZU;2-A